Literature DB >> 22957899

Enhanced and selective killing of chronic myelogenous leukemia cells with an engineered BCR-ABL binding protein and imatinib.

Jonathan E Constance1, David W Woessner, Karina J Matissek, Mohanad Mossalam, Carol S Lim.   

Abstract

The oncoprotein Bcr-Abl stimulates prosurvival pathways and suppresses apoptosis from its exclusively cytoplasmic locale, but when targeted to the mitochondrial compartment of leukemia cells, Bcr-Abl was potently cytotoxic. Therefore, we designed a protein construct to act as a mitochondrial chaperone to move Bcr-Abl to the mitochondria. The chaperone (i.e., the 43.6 kDa intracellular cryptic escort (iCE)) contains an EGFP tag and two previously characterized motifs: (1) an optimized Bcr-Abl binding motif that interacts with the coiled-coil domain of Bcr (ccmut3; 72 residues), and (2) a cryptic mitochondrial targeting signal (cMTS; 51 residues) that selectively targets the mitochondria in oxidatively stressed cells (i.e., Bcr-Abl positive leukemic cells) via phosphorylation at a key residue (T193) by protein kinase C. While the iCE colocalized with Bcr-Abl, it did not relocalize to the mitochondria. However, the iCE was selectively toxic to Bcr-Abl positive K562 cells as compared to Bcr-Abl negative Cos-7 fibroblasts and 1471.1 murine breast cancer cells. The toxicity of the iCE to leukemic cells was equivalent to 10 μM imatinib at 48 h and the iCE combined with imatinib potentiated cell death beyond imatinib or the iCE alone. Substitution of either the ccmut3 or the cMTS with another Bcr-Abl binding domain (derived from Ras/Rab interaction protein 1 (RIN1; 295 residues)) or MTS (i.e., the canonical IMS derived from Smac/Diablo; 49 residues) did not match the cytotoxicity of the iCE. Additionally, a phosphorylation null mutant of the iCE also abolished the killing effect. The mitochondrial toxicity of Bcr-Abl and the iCE in Bcr-Abl positive K562 leukemia cells was confirmed by flow cytometric analysis of 7-AAD, TUNEL, and annexin-V staining. DNA segmentation and cell viability were assessed by microscopy. Subcellular localization of constructs was determined using confocal microscopy (including statistical colocalization analysis). Overall, the iCE was highly active against K562 leukemia cells and the killing effect was dependent upon both the ccmut3 and functional cMTS domains.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22957899      PMCID: PMC3529210          DOI: 10.1021/mp3003539

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  38 in total

1.  Targeting of the c-Abl tyrosine kinase to mitochondria in the necrotic cell death response to oxidative stress.

Authors:  S Kumar; A Bharti; N C Mishra; D Raina; S Kharbanda; S Saxena; D Kufe
Journal:  J Biol Chem       Date:  2001-02-28       Impact factor: 5.157

2.  The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells.

Authors:  M Sattler; S Verma; G Shrikhande; C H Byrne; Y B Pride; T Winkler; E A Greenfield; R Salgia; J D Griffin
Journal:  J Biol Chem       Date:  2000-08-11       Impact factor: 5.157

3.  Phosphorylation enhances mitochondrial targeting of GSTA4-4 through increased affinity for binding to cytoplasmic Hsp70.

Authors:  Marie-Anne Robin; Subbuswamy K Prabu; Haider Raza; Hindupur K Anandatheerthavarada; Narayan G Avadhani
Journal:  J Biol Chem       Date:  2003-03-19       Impact factor: 5.157

4.  A guided tour into subcellular colocalization analysis in light microscopy.

Authors:  S Bolte; F P Cordelières
Journal:  J Microsc       Date:  2006-12       Impact factor: 1.758

5.  Regulation of the oncogenic activity of BCR-ABL by a tightly bound substrate protein RIN1.

Authors:  D E Afar; L Han; J McLaughlin; S Wong; A Dhaka; K Parmar; N Rosenberg; O N Witte; J Colicelli
Journal:  Immunity       Date:  1997-06       Impact factor: 31.745

6.  Disruption of Bcr-Abl coiled coil oligomerization by design.

Authors:  Andrew S Dixon; Scott S Pendley; Benjamin J Bruno; David W Woessner; Adrian A Shimpi; Thomas E Cheatham; Carol S Lim
Journal:  J Biol Chem       Date:  2011-06-09       Impact factor: 5.157

Review 7.  Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure.

Authors:  M van Engeland; L J Nieland; F C Ramaekers; B Schutte; C P Reutelingsperger
Journal:  Cytometry       Date:  1998-01-01

8.  Structural basis for the cytoskeletal association of Bcr-Abl/c-Abl.

Authors:  Oliver Hantschel; Silke Wiesner; Thomas Güttler; Cameron D Mackereth; Lily L Remsing Rix; Zsuzsanna Mikes; Jana Dehne; Dirk Görlich; Michael Sattler; Giulio Superti-Furga
Journal:  Mol Cell       Date:  2005-08-19       Impact factor: 17.970

9.  14-3-3 ligand prevents nuclear import of c-ABL protein in chronic myeloid leukemia.

Authors:  Manuela Mancini; Nevena Veljkovic; Valentina Corradi; Elisa Zuffa; Patrizia Corrado; Eleonora Pagnotta; Giovanni Martinelli; Enza Barbieri; Maria Alessandra Santucci
Journal:  Traffic       Date:  2009-02-11       Impact factor: 6.215

10.  Trypan blue exclusion test of cell viability.

Authors:  W Strober
Journal:  Curr Protoc Immunol       Date:  2001-05
View more
  3 in total

1.  Delivery of a monomeric p53 subdomain with mitochondrial targeting signals from pro-apoptotic Bak or Bax.

Authors:  Karina J Matissek; Abood Okal; Mohanad Mossalam; Carol S Lim
Journal:  Pharm Res       Date:  2014-03-15       Impact factor: 4.200

Review 2.  Therapy of chronic myeloid leukemia: twilight of the imatinib era?

Authors:  Ewelina Trela; Sylwester Glowacki; Janusz Błasiak
Journal:  ISRN Oncol       Date:  2014-01-30

3.  Imatinib induces up-regulation of NM23, a metastasis suppressor gene, in human Hepatocarcinoma (HepG2) Cell Line.

Authors:  Behta Keshavarz-Pakseresht; Seyed Ataollah Sadat Shandiz; Fahimeh Baghbani-Arani
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.